TGTX - TG Therapeutics GAAP EPS of -$0.07 misses by $0.03 revenue of $63.47M beats by $8.86M
2024-05-01 07:25:14 ET
More on TG Therapeutics
- TG Therapeutics: The Cloud Over Briumvi
- TG Therapeutics: BRIUMVI Development Could Lead To Great Results
- TG Therapeutics: Briumvi Growth Story Appears Intact
- TG Therapeutics wins VA contract for Briumvi
- TG Therapeutics jumps after second consecutive quarterly beat